Concepedia

Jacqueline C. Newby

JC

Statistics

Publications

7

Citations

864

H-Index

7

Active since

1995

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

Peterborough City Hospital

University of Cambridge

Cancer Research UK Cambridge Center

University Hospital Southampton NHS Foundation Trust

Jacqueline C. Newby is an author at Cambridge University Hospitals NHS Foundation Trust specializing in tumor biology, oncology, and medicine.

Top concepts

Publications per year

1995–2024

7

Publications

7

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

S R Johnston, Gloria Saccani‐Jotti, I. E. Smith et al. · PubMed · 1995 · 304 citations

, , +14

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 277 citations · Full text

Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.

Jacqueline C. Newby, Stephen Johnston, I E Smith et al. · PubMed · 1997 · 192 citations

, , +16

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

Jean Abraham, Karen Pinilla, Alimu Dayimu et al. · Nature · 2024 · 37 citations · Full text

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

M.A. Bergamino, Elena López‐Knowles, Gabriele Morani et al. · EBioMedicine · 2022 · 25 citations · Full text

1–5 of 7